Gilead, IPA, Natco & The Bells of Harmony
The post examines the collaboration between Gilead, IPA, and Natco Pharma regarding the sofosbuvir patent in India. It analyses how voluntary licensing and innovative policies are improving access…
1,285 articles
The post examines the collaboration between Gilead, IPA, and Natco Pharma regarding the sofosbuvir patent in India. It analyses how voluntary licensing and innovative policies are improving access…
The post explores how Ganesha idols intersect with patent law and eco-friendly innovations during Ganesh Chaturthi. It highlights inventive methods of idol making and their legal implications in…
TiVo has sued Samsung for allegedly infringing four of its multimedia technology patents, targeting both set-top boxes and mobile devices. This litigation highlights TiVo’s ongoing strategy to protect…
The Delhi High Court granted an interim injunction to Ericsson against iBall in a significant patent infringement dispute involving standard essential patents for mobile technologies. The court found…
An Indian food scientist has patented a process to produce tequila-like alcohol from Agave albomarginata, a plant native to the Rayalseema region. The innovation uses the plant’s high-starch…
This post examines Pfizer’s patent application on a known substance and the Indian Patent Office’s refusal in light of Section 3d and the Novartis decision. It discusses whether…
This post analyses the Indian Patent Office’s rejection of Pfizer’s Tofacitinib patent under Section 3(d). The decision addresses issues of novelty, inventive step, and the requirement for evidence…
This article critically examines the working of patents in India, focusing on statutory requirements, compulsory licensing, and judicial interpretations. It discusses both commercial and non-commercial working, highlighting the…
NSRCEL at IIM Bangalore organised a well-received event on intellectual property for startups. The programme offered practical guidance and resources to help entrepreneurs manage and protect their IP…
This post examines the Lee Pharma v. AstraZeneca case on compulsory licensing under Indian patent law. The Controller’s decision sheds light on the standards for proving public need,…